3D-PharmXchange is a drug development consultancy supporting biotech and pharmaceutical companies as well as academic teams in advancing innovative therapeutic programs. We provide strategic and industry-seasoned development expertise, spanning CMC, non-clinical, clinical development, regulatory affairs, quality assurance, and multidisciplinary project management.

Core activities

• Early-stage development strategy for emerging innovators
• Guidance for first-/best-in-class or disruptive therapies
• Outsourcing strategy and management (manufacturing, non-clinical studies, clinical trials)
• Regulatory authority interactions (EMA, FDA, national bodies)
• Protocol development and innovative study design
•  Translation of academic projects toward clinical development

Therapeutic modalities

• Small molecules
• Biologics (antibodies, bispecifics, ADCs)
• Advanced therapies (cell & gene therapy/ATMPs)